Market cap
$1,186 Mln
Revenue (TTM)
$337 Mln
P/E Ratio
--
P/B Ratio
3.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.3 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-24.6
-
Debt to Equity
0.2
-
Book Value
$5.9
-
EPS
$-2
-
Face value
--
-
Shares outstanding
56,918,844
5 Years Aggregate
CFO
$-337.88 Mln
EBITDA
$-323.86 Mln
Net Profit
$-362.77 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Procept Biorobotics Corp (PRCT)
| -33.8 | 17.8 | -21.3 | -48.9 | -12.3 | -- | -- |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Procept Biorobotics Corp (PRCT)
| -60.9 | 91.1 | 0.9 | 66.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Procept Biorobotics Corp (PRCT)
|
20.8 | 1,185.6 | 337.3 | -109.8 | -31.4 | -31.1 | -- | 3.5 |
| 61.5 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.1 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.8 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 321.7 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 176.3 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 | |
| 29.0 | 12,153.4 | 6,164.0 | 625.0 | 13.0 | 11.8 | 19.9 | 2.4 |
Shareholding Pattern
View DetailsAbout Procept Biorobotics Corp (PRCT)
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic... system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California. Read more
-
President, CEO & Director
Dr. Reza Zadno Ph.D.
-
President, CEO & Director
Dr. Reza Zadno Ph.D.
-
Headquarters
San Jose, CA
-
Website
FAQs for Procept Biorobotics Corp (PRCT)
What is the current share price of Procept Biorobotics Corp (PRCT) Today?
The share price of Procept Biorobotics Corp (PRCT) is $20.83 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Procept Biorobotics Corp (PRCT) has given a return of -12.3% in the last 3 years.
What is the current PB & PE ratio of Procept Biorobotics Corp (PRCT)?
Since, TTM earnings of Procept Biorobotics Corp (PRCT) is negative, P/E ratio is not available.
The P/B ratio of Procept Biorobotics Corp (PRCT) is 3.47 times as on 28-Aug-2026, a 8 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-18.46 |
4.82 |
2024 |
-47.42 |
10.78 |
2023 |
-20.02 |
7.55 |
2022 |
-21.34 |
9.44 |
2021 |
-18.19 |
4.08 |
What is the 52 Week High and Low of Procept Biorobotics Corp (PRCT)?
The 52-week high and low of Procept Biorobotics Corp (PRCT) are Rs 42.43 and Rs 16.67 as of 31-Aug-2026.
What is the market cap of Procept Biorobotics Corp (PRCT)?
Procept Biorobotics Corp (PRCT) has a market capitalisation of $ 1,186 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Procept Biorobotics Corp (PRCT)?
Before investing in Procept Biorobotics Corp (PRCT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.